Sayour, A.A.; Ruppert, M.; Oláh, A.; Benke, K.; Barta, B.A.; Zsáry, E.; Merkely, B.; Radovits, T.
Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1. Int. J. Mol. Sci. 2021, 22, 9852.
https://doi.org/10.3390/ijms22189852
AMA Style
Sayour AA, Ruppert M, Oláh A, Benke K, Barta BA, Zsáry E, Merkely B, Radovits T.
Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1. International Journal of Molecular Sciences. 2021; 22(18):9852.
https://doi.org/10.3390/ijms22189852
Chicago/Turabian Style
Sayour, Alex Ali, Mihály Ruppert, Attila Oláh, Kálmán Benke, Bálint András Barta, Eszter Zsáry, Béla Merkely, and Tamás Radovits.
2021. "Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1" International Journal of Molecular Sciences 22, no. 18: 9852.
https://doi.org/10.3390/ijms22189852
APA Style
Sayour, A. A., Ruppert, M., Oláh, A., Benke, K., Barta, B. A., Zsáry, E., Merkely, B., & Radovits, T.
(2021). Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1. International Journal of Molecular Sciences, 22(18), 9852.
https://doi.org/10.3390/ijms22189852